Table 3 Comparison between NTS bacteraemia patients with or without severe immunosuppression

Yes (n = 36)

No(n = 19)

Age > 50 ^a

18(32.7)

6(16.7)

12(63.2)

0.001

0.12

0.03–0.42

Male ^b

37(67.3)

24(66.7)

13(68.4)

0.89

0.92

0.28–3.034

EF1 ^b

17(30.9)

10(27.8)

7(36.8)

0.49

0.66

0.20–2.15

Mycotic aneurysm ^a

3(5.5)

0(0)

3(15.8)

0.037

undefined

Gastroenteritis ^b

16(29.1)

7(19.4)

9(47.4)

0.03

0.27

0.079–0.91

Primary bacteraemia ^b

23(41.8)

19(52.8)

4 (21.1)

0.023

4.19

1.16–15.11

Atherosclerosis ^a

12(21.8)

4(11.1)

8(42.1)

0.015

0.17

0.043–0.69

Mortality^a

12(21.8)

11(30.6)

1(5.3)

0.041

7.92

0.94–66.97

Salmonella Enteritidis ^b

40(72.7)

29(80.6)

11(57.9)

0.073

3.013

0.88–10.30

Group D Salmonella^a

43(78.2)

31(86.1)

12(63.2)

0.084

3.62

0.96–13.64

Hospital acquisition ^a

10(18.2)

9(25.0)

1 (5.3)

0.14

6

0.70–51.53

Septic shock ^a

5(9.1)

4(11.1)

1(5.3)

0.65

2.25

0.23–21.69

Fever ^a

42(76.4)

27(75)

15(78.9)

1.00

1.25

0.33–4.76

Paediatric ^a

13(23.6)

10(27.8)

3(15.8)

0.51

0.49

0.12–2.04

Opportunistic infections ^a

11(20)

11(30.6)

0(0)

0.01

Undefined

Leukopenia ^b

15(27.3)

15(41.6)

0(0)

0.001

undefined

Blood culture positivity < 24 hours ^b

35(63.6)

24(66.7)

11(57.9)

0.52

1.45

0.46–4.57

Age (years) ^c

39(43.0)

36.5(31.25)

64.0(41.0)

0.005

NA

Duration of hospitalization (days) ^c

9(13.0)

8.0(16.0)

10.0(12.0)

0.18

NA

Leukocytes/mm^3c

7.7(7.0)

5.5(7.18)

8.3(5.7)

0.016

NA

Lymphocytes/mm^{3 c}

1.1(1.4)

0.9(1.0)

1.9(2.2)

0.026

NA

Duration of symptoms (days) ^c

5(4.0)

5.0(4.0)

5.0(4.0)

0.98

NA